戻る Agenda
Session 6 Track C - Pharmacovigilance and Risk Management: Pharmacovigilance Systems/Models and eReporting
Session Chair(s)
Chanez Narimene Kebache, MBA
Director, Global Product Safety & Pharmacovigilance
Canopy Growth Corporation, Canada
The session will discuss different pharmacovigilance systems/models used by the industry for the continuous monitoring of therapeutic health products. The session will also include an update from Health Canada and a Q&A on eReporting.
Speaker(s)
Designing a Pharmacovigilance System - Options and Strategies
Miranda Dollen
Akebia Therapeutics, United States
Consultant
A Look at a Hybrid Pharmacovigilance System
Diana Basmadjian, RPH
Sanofi Canada Inc., Canada
Americas Region Safety Head/Canada Safety Head
Q&A: eReporting
Mary J. Raphael
Health Canada, Canada
Director, Marketed Health Products Safety and Effectiveness Information Bureau
with
Valerie Bergeron
Health Canada, Canada
Adverse Reaction Terminology Specialist, Marketed Health Products Directorate